BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 34271420)

  • 1. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19.
    El-Behery H; Attia AF; El-Feshawy N; Torkey H
    Comput Biol Chem; 2021 Aug; 93():107536. PubMed ID: 34271420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing drug-target interaction prediction: a comprehensive graph-based approach integrating knowledge graph embedding and ProtBert pretraining.
    Djeddi WE; Hermi K; Ben Yahia S; Diallo G
    BMC Bioinformatics; 2023 Dec; 24(1):488. PubMed ID: 38114937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PreDTIs: prediction of drug-target interactions based on multiple feature information using gradient boosting framework with data balancing and feature selection techniques.
    Mahmud SMH; Chen W; Liu Y; Awal MA; Ahmed K; Rahman MH; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33709119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of network-based approaches and machine learning algorithms for predicting drug-target interactions.
    Jung YS; Kim Y; Cho YR
    Methods; 2022 Feb; 198():19-31. PubMed ID: 34737033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DeepStack-DTIs: Predicting Drug-Target Interactions Using LightGBM Feature Selection and Deep-Stacked Ensemble Classifier.
    Zhang Y; Jiang Z; Chen C; Wei Q; Gu H; Yu B
    Interdiscip Sci; 2022 Jun; 14(2):311-330. PubMed ID: 34731411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Target Interaction Prediction Using Multi-Head Self-Attention and Graph Attention Network.
    Cheng Z; Yan C; Wu FX; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(4):2208-2218. PubMed ID: 33956632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMMVF-DTI: A Novel Model Predicting Drug-Target Interactions Based on Attention Mechanism and Multi-View Fusion.
    Wang L; Zhou Y; Chen Q
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features.
    Chu Y; Kaushik AC; Wang X; Wang W; Zhang Y; Shan X; Salahub DR; Xiong Y; Wei DQ
    Brief Bioinform; 2021 Jan; 22(1):451-462. PubMed ID: 31885041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
    Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
    Elife; 2022 Nov; 11():. PubMed ID: 36416537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning.
    Azmoodeh SK; Tsigelny IF; Kouznetsova VL
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):113. PubMed ID: 35468672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel drug-target interactions via link prediction and network embedding.
    Amiri Souri E; Laddach R; Karagiannis SN; Papageorgiou LG; Tsoka S
    BMC Bioinformatics; 2022 Apr; 23(1):121. PubMed ID: 35379165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeepACTION: A deep learning-based method for predicting novel drug-target interactions.
    Hasan Mahmud SM; Chen W; Jahan H; Dai B; Din SU; Dzisoo AM
    Anal Biochem; 2020 Dec; 610():113978. PubMed ID: 33035462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-target interaction prediction with tree-ensemble learning and output space reconstruction.
    Pliakos K; Vens C
    BMC Bioinformatics; 2020 Feb; 21(1):49. PubMed ID: 32033537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting drug-target interactions using restricted Boltzmann machines.
    Wang Y; Zeng J
    Bioinformatics; 2013 Jul; 29(13):i126-34. PubMed ID: 23812976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.
    Mongia A; Saha SK; Chouzenoux E; Majumdar A
    Sci Rep; 2021 Apr; 11(1):9047. PubMed ID: 33907209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to approach machine learning-based prediction of drug/compound-target interactions.
    Atas Guvenilir H; Doğan T
    J Cheminform; 2023 Feb; 15(1):16. PubMed ID: 36747300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach.
    Monteiro NRC; Ribeiro B; Arrais JP
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2364-2374. PubMed ID: 32142454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.